{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:29:28Z","timestamp":1794360568578,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institutes of Health","award":["R61NS119639"],"award-info":[{"award-number":["R61NS119639"]}]},{"DOI":"10.13039\/100005693","name":"Parent Project Muscular Dystrophy","doi-asserted-by":"publisher","award":["22.010"],"award-info":[{"award-number":["22.010"]}],"id":[{"id":"10.13039\/100005693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Muscle"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disorder for which monitoring biomarkers are urgently needed. We aimed to evaluate whether proteins in serum can accurately monitor patients' function within the duration of a clinical trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we evaluated longitudinal serum proteins of DMD patients participating in the FOR-DMD clinical trial, comparing daily and intermittent corticosteroid regimens in boys aged 4\u20138\u00a0years at baseline. Using the aptamer-based protein platform SomaScan, we profiled 1500 proteins. Associations between protein levels and motor function outcomes, such as Rise from the Floor Velocity (RFV), 10-Meter Run\/Walk Velocity (10MRWV), and North Star Ambulatory Assessment (NSAA), were assessed using linear mixed models. In particular, we explored whether patients with higher protein levels also tended to have better functional scores (across-patients analysis), and whether changes in protein levels within the same patient over time were linked to changes in their functional performance (within-patient analysis). Finally, penalized (lasso) mixed models were applied to evaluate the predictive function of the proteins. The prediction accuracy of the models (evaluated by optimism-corrected Root Mean Squared Error) was compared to that of a simpler model with only age and treatment as predictors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Across-patients and within-patient analyses revealed consistent associations with three functional tests for a subset of proteins, notably RGMA, ART3, ANTXR2, and CFB. Multivariate models incorporating the proteins significantly associated with at least two tests, improved prediction accuracy by 12% for NSAA, and by\u00a033\u201335% for RFV and 10MRWV. These models also revealed a subset of proteins that were consistently selected. Quantification of CFB, RGMA, ANTXR2, SERPINF1 and ATP5PF using SomaScan showed strong agreement with measurements obtained using orthogonal methods such as ELISA, MRM-MS and an in-house developed bead-based sandwich immunoassay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings support the utility of serum protein signatures as objective, quantitative tools for monitoring disease progression and treatment response in DMD during clinical visits and clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The FOR-DMD clinical trial was registered at ClinicalTrials.gov\u202f(registration no. NCT01603407). First submission: 03\/04\/2012.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13395-026-00437-2","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:45:25Z","timestamp":1783943125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of a serum protein signature as monitoring biomarker for Duchenne muscular dystrophy in a long-term clinical trial with corticosteroids"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9993-9346","authenticated-orcid":false,"given":"Chiara","family":"Degan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon I.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Jim\u00e9nez-Requena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amela","family":"Peco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Guglieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Diaz-Manera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri E. M.","family":"van der Burgt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J. M.","family":"van Vlijmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"FOR-DMD investigators of the Muscle Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Bushby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabi","family":"Tawil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara E.","family":"Herr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"McColl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Speed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janbernd","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy M.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Eagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary W.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Griggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"van Ruiten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Ciafaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry B.","family":"Shieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Spinty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Baranello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell J.","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. A.","family":"Horrocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Roper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoya","family":"Alhaswani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Flanigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Kuntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Manzur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil T.","family":"Darras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Krzesniak-Swinarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean K.","family":"Mah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana E.","family":"Mongini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"von der Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Finkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"O\u2019Reardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Wicklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig M.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay J.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanette","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik K.","family":"Henricson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Schara-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gangfus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Wilichowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Barohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Statland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luca","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"James","family":"FHoward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imelda","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh J.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WBryan","family":"Burnette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathula","family":"Thangarajh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yetrib","family":"Hathout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Al-Khalili","family":"Szigyarto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utkarsh J.","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roula","family":"Tsonaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Spitali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"437_CR1","doi-asserted-by":"publisher","unstructured":"Degan C, Tsonaka R, Vries SI de, et al. Creatine\/creatinine ratio and myostatin as biomarkers to monitor muscle function in Duchenne Muscular Dystrophy patients. medRxiv. Preprint posted online August 14, 2025:2025.08.11.25333307. https:\/\/doi.org\/10.1101\/2025.08.11.25333307.","DOI":"10.1101\/2025.08.11.25333307"},{"issue":"6","key":"437_CR2","doi-asserted-by":"publisher","first-page":"e0325736","DOI":"10.1371\/JOURNAL.PONE.0325736","volume":"20","author":"F Muntoni","year":"2025","unstructured":"Muntoni F, Signorovitch J, Goemans N, et al. Predicting trajectories of the north star ambulatory assessment total score in Duchenne muscular dystrophy. PLoS One. 2025;20(6):e0325736. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0325736.","journal-title":"PLoS One"},{"issue":"5","key":"437_CR3","doi-asserted-by":"publisher","first-page":"e200289","DOI":"10.1212\/NXG.0000000000200289","volume":"11","author":"RA Tobin","year":"2025","unstructured":"Tobin RA, Hoffman EP, Johnson L, et al. Test-retest reliability of motor function and myometry outcomes from the vamorolone trials in Duchenne muscular dystrophy. Neurol Genet. 2025;11(5):e200289. https:\/\/doi.org\/10.1212\/NXG.0000000000200289.","journal-title":"Neurol Genet"},{"issue":"7","key":"437_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.nmd.2019.06.003","volume":"29","author":"M Haberkamp","year":"2019","unstructured":"Haberkamp M, Moseley J, Athanasiou D, et al. European regulators\u2019 views on a wearable-derived performance measurement of ambulation for Duchenne muscular dystrophy regulatory trials. Neuromuscul Disord. 2019;29(7):514\u20136. https:\/\/doi.org\/10.1016\/j.nmd.2019.06.003.","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"437_CR5","doi-asserted-by":"publisher","first-page":"e897","DOI":"10.1212\/WNL.0000000000009012","volume":"94","author":"AM Barnard","year":"2020","unstructured":"Barnard AM, Willcocks RJ, Triplett WT, et al. MR biomarkers predict clinical function in Duchenne muscular dystrophy. Neurology. 2020;94(9):e897\u2013909. https:\/\/doi.org\/10.1212\/WNL.0000000000009012.","journal-title":"Neurology"},{"issue":"1","key":"437_CR6","doi-asserted-by":"publisher","first-page":"9073","DOI":"10.1038\/s41467-025-64146-y","volume":"16","author":"NA Ikelaar","year":"2025","unstructured":"Ikelaar NA, Barnard AM, Eng SWM, et al. Large-scale serum protein biomarkers discovery associated with function and clinical milestones in Duchenne muscular dystrophy. Nat Commun. 2025;16(1):9073. https:\/\/doi.org\/10.1038\/s41467-025-64146-y.","journal-title":"Nat Commun"},{"issue":"23","key":"437_CR7","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.1073\/pnas.1507719112","volume":"112","author":"Y Hathout","year":"2015","unstructured":"Hathout Y, Brody E, Clemens PR, et al. Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy. Proc Natl Acad Sci. 2015;112(23):7153\u20138. https:\/\/doi.org\/10.1073\/pnas.1507719112.","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"437_CR8","doi-asserted-by":"publisher","first-page":"918","DOI":"10.15252\/emmm.201303724","volume":"6","author":"B Ayoglu","year":"2014","unstructured":"Ayoglu B, Chaouch A, Lochm\u00fcller H, et al. Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies. EMBO Mol Med. 2014;6(7):918\u201336. https:\/\/doi.org\/10.15252\/emmm.201303724.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"437_CR9","doi-asserted-by":"publisher","first-page":"12167","DOI":"10.1038\/s41598-019-48548-9","volume":"9","author":"Y Hathout","year":"2019","unstructured":"Hathout Y, Liang C, Ogundele M, et al. Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne muscular dystrophy. Sci Rep. 2019;9(1):12167. https:\/\/doi.org\/10.1038\/s41598-019-48548-9.","journal-title":"Sci Rep"},{"issue":"1","key":"437_CR10","doi-asserted-by":"publisher","first-page":"39997","DOI":"10.1038\/s41598-025-23758-6","volume":"15","author":"F Ahmadiharchegani","year":"2025","unstructured":"Ahmadiharchegani F, Tobin RA, Degan C, et al. Circulating protein biomarkers identified in two independent clinical trial cohorts of glucocorticoid-naive Duchenne muscular dystrophy patients. Sci Rep. 2025;15(1):39997. https:\/\/doi.org\/10.1038\/s41598-025-23758-6.","journal-title":"Sci Rep"},{"issue":"4","key":"437_CR11","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/jcsm.12304","volume":"9","author":"P Spitali","year":"2018","unstructured":"Spitali P, Hettne K, Tsonaka R, et al. Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies. J Cachexia Sarcopenia Muscle. 2018;9(4):715\u201326. https:\/\/doi.org\/10.1002\/jcsm.12304.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"437_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11897-022-00541-6","volume":"19","author":"T Lee-Gannon","year":"2022","unstructured":"Lee-Gannon T, Jiang X, Tassin TC, Mammen PPA. Biomarkers in Duchenne muscular dystrophy. Curr Heart Fail Rep. 2022;19(2):52\u201362. https:\/\/doi.org\/10.1007\/s11897-022-00541-6.","journal-title":"Curr Heart Fail Rep"},{"issue":"6","key":"437_CR13","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3233\/JND-221666","volume":"10","author":"F Fortunato","year":"2023","unstructured":"Fortunato F, Ferlini A. Biomarkers in Duchenne muscular dystrophy: current status and future directions. J Neuromuscul Dis. 2023;10(6):987\u20131002. https:\/\/doi.org\/10.3233\/JND-221666.","journal-title":"J Neuromuscul Dis"},{"issue":"4","key":"437_CR14","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1111\/jcmm.13543","volume":"22","author":"P Spitali","year":"2018","unstructured":"Spitali P, Hettne K, Tsonaka R, et al. Cross-sectional serum metabolomic study of multiple forms of muscular dystrophy. J Cell Mol Med. 2018;22(4):2442\u20138. https:\/\/doi.org\/10.1111\/jcmm.13543.","journal-title":"J Cell Mol Med"},{"issue":"15","key":"437_CR15","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1093\/hmg\/ddaa132","volume":"29","author":"UJ Dang","year":"2020","unstructured":"Dang UJ, Ziemba M, Clemens PR, et al. Serum biomarkers associated with baseline clinical severity in young steroid-na\u00efve Duchenne muscular dystrophy boys. Hum Mol Genet. 2020;29(15):2481. https:\/\/doi.org\/10.1093\/hmg\/ddaa132.","journal-title":"Hum Mol Genet"},{"issue":"15","key":"437_CR16","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1001\/jama.2022.4315","volume":"327","author":"M Guglieri","year":"2022","unstructured":"Guglieri M, Bushby K, McDermott MP, et al. Effect of different corticosteroid dosing regimens on clinical outcomes in boys with Duchenne muscular dystrophy: a randomized clinical trial. JAMA. 2022;327(15):1456\u201368. https:\/\/doi.org\/10.1001\/jama.2022.4315.","journal-title":"JAMA"},{"issue":"3","key":"437_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3233\/JND-190454","volume":"7","author":"K Strandberg","year":"2020","unstructured":"Strandberg K, Ayoglu B, Roos A, et al. Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy. J Neuromuscul Dis. 2020;7(3):231. https:\/\/doi.org\/10.3233\/JND-190454.","journal-title":"J Neuromuscul Dis"},{"issue":"2","key":"437_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jcsm.12517","volume":"11","author":"M Signorelli","year":"2020","unstructured":"Signorelli M, Ayoglu B, Johansson C, et al. Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy. J Cachexia Sarcopenia Muscle. 2020;11(2):505\u201317. https:\/\/doi.org\/10.1002\/jcsm.12517.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"41","key":"437_CR19","doi-asserted-by":"publisher","first-page":"26504","DOI":"10.1021\/acsomega.0c03206","volume":"5","author":"TD Alayi","year":"2020","unstructured":"Alayi TD, Tawalbeh SM, Ogundele M, et al. Tandem mass tag-based serum proteome profiling for biomarker discovery in young Duchenne muscular dystrophy boys. ACS Omega. 2020;5(41):26504\u201317. https:\/\/doi.org\/10.1021\/acsomega.0c03206.","journal-title":"ACS Omega"},{"issue":"12","key":"437_CR20","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1038\/s41591-019-0665-2","volume":"25","author":"SA Williams","year":"2019","unstructured":"Williams SA, Kivimaki M, Langenberg C, et al. Plasma protein patterns as comprehensive indicators of health. Nat Med. 2019;25(12):1851\u20137. https:\/\/doi.org\/10.1038\/s41591-019-0665-2.","journal-title":"Nat Med"},{"issue":"27","key":"437_CR21","doi-asserted-by":"publisher","first-page":"6178","DOI":"10.1002\/sim.9178","volume":"40","author":"M Signorelli","year":"2021","unstructured":"Signorelli M, Spitali P, Szigyarto CAK, MARK-MD Consortium, Tsonaka R. Penalized regression calibration: a method for the prediction of survival outcomes using complex longitudinal and high-dimensional data. Stat Med. 2021;40(27):6178\u201396. https:\/\/doi.org\/10.1002\/sim.9178.","journal-title":"Stat Med"},{"issue":"4","key":"437_CR22","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.neuroimage.2010.12.028","volume":"55","author":"F Bunea","year":"2011","unstructured":"Bunea F, She Y, Ombao H, Gongvatana A, Devlin K, Cohen R. Penalized least squares regression methods and applications to neuroimaging. Neuroimage. 2011;55(4):1519\u201327. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.12.028.","journal-title":"Neuroimage"},{"issue":"1","key":"437_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Soft. 2015;67(1):1\u201348. https:\/\/doi.org\/10.18637\/jss.v067.i01.","journal-title":"J Stat Soft"},{"key":"437_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v082.i13","volume":"82","author":"A Kuznetsova","year":"2017","unstructured":"Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest package: tests in linear mixed effects models. J Stat Soft. 2017;82:1\u201326. https:\/\/doi.org\/10.18637\/jss.v082.i13.","journal-title":"J Stat Soft"},{"issue":"2","key":"437_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11222-012-9359-z","volume":"24","author":"A Groll","year":"2014","unstructured":"Groll A, Tutz G. Variable selection for generalized linear mixed models by L1-penalized estimation. Stat Comput. 2014;24(2):137\u201354. https:\/\/doi.org\/10.1007\/s11222-012-9359-z.","journal-title":"Stat Comput"},{"issue":"5","key":"437_CR26","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3233\/JND-240061","volume":"11","author":"NM van de Velde","year":"2024","unstructured":"van de Velde NM, Krom YD, Bongers J, et al. The Dutch dystrophinopathy database: a national registry with standardized patient and clinician reported real-world data. J Neuromuscul Dis. 2024;11(5):1095\u2013109. https:\/\/doi.org\/10.3233\/JND-240061.","journal-title":"J Neuromuscul Dis"},{"key":"437_CR27","doi-asserted-by":"publisher","unstructured":"Mohammed Y, Goodlett D, Borchers CH. Absolute quantitative targeted proteomics assays for plasma proteins. In: Greening DW, Simpson RJ, eds. Serum\/Plasma Proteomics: Methods and Protocols. Springer US; 2023. pp. 439-473. https:\/\/doi.org\/10.1007\/978-1-0716-2978-9_27.","DOI":"10.1007\/978-1-0716-2978-9_27"},{"key":"437_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1479-5876-9-82","volume":"9","author":"CJ Huang","year":"2011","unstructured":"Huang CJ, Yang SH, Huang SM, et al. A predicted protein, KIAA0247, is a cell cycle modulator in colorectal cancer cells under 5-FU treatment. J Transl Med. 2011;9:82. https:\/\/doi.org\/10.1186\/1479-5876-9-82.","journal-title":"J Transl Med"},{"key":"437_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jmsacl.2022.12.007","volume":"27","author":"N Diederiks","year":"2022","unstructured":"Diederiks N, Ravensbergen CJ, Treep M, et al. Development of tier 2 LC-MRM-MS protein quantification methods for liquid biopsies. J Mass Spectrom Adv Clin Lab. 2022;27:49\u201355. https:\/\/doi.org\/10.1016\/j.jmsacl.2022.12.007.","journal-title":"J Mass Spectrom Adv Clin Lab"},{"issue":"0","key":"437_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14789450.2025.2557023","volume":"0","author":"Y Mohammed","year":"2025","unstructured":"Mohammed Y, Bhowmick P, Borchers CH. MRMAssayDB: a comprehensive integrated resource for targeted proteomics assays. Expert Rev Proteomics. 2025;0(0):1\u201312. https:\/\/doi.org\/10.1080\/14789450.2025.2557023.","journal-title":"Expert Rev Proteomics"},{"issue":"3","key":"437_CR31","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1074\/mcp.M113.036095","volume":"13","author":"SA Carr","year":"2014","unstructured":"Carr SA, Abbatiello SE, Ackermann BL, et al. Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach*. Mol Cell Proteomics. 2014;13(3):907\u201317. https:\/\/doi.org\/10.1074\/mcp.M113.036095.","journal-title":"Mol Cell Proteomics"},{"issue":"6220","key":"437_CR32","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, et al. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419. https:\/\/doi.org\/10.1126\/science.1260419.","journal-title":"Science"},{"issue":"1","key":"437_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12014-023-09412-1","volume":"20","author":"C Johansson","year":"2023","unstructured":"Johansson C, Hunt H, Signorelli M, et al. Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers. Clin Proteom. 2023;20(1):23. https:\/\/doi.org\/10.1186\/s12014-023-09412-1.","journal-title":"Clin Proteom"},{"issue":"7","key":"437_CR34","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1021\/acs.jproteome.8b00924","volume":"18","author":"F Edfors","year":"2019","unstructured":"Edfors F, Forsstr\u00f6m B, Vunk H, et al. Screening a resource of recombinant protein fragments for targeted proteomics. J Proteome Res. 2019;18(7):2706\u201318. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00924.","journal-title":"J Proteome Res"},{"issue":"2","key":"437_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0169-7439(93)80008-6","volume":"20","author":"MA O\u2019Connell","year":"1993","unstructured":"O\u2019Connell MA, Belanger BA, Haaland PD. Calibration and assay development using the four-parameter logistic model. Chemom Intell Lab Syst. 1993;20(2):97\u2013114. https:\/\/doi.org\/10.1016\/0169-7439(93)80008-6.","journal-title":"Chemom Intell Lab Syst"},{"issue":"13","key":"437_CR36","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1021\/ac051632c","volume":"78","author":"F Dieterle","year":"2006","unstructured":"Dieterle F, Ross A, Schlotterbeck G, Senn H. Probabilistic Quotient Normalization as Robust Method to Account for Dilution of Complex Biological Mixtures. Application in 1H NMR Metabonomics. Anal Chem. 2006;78(13):4281\u201390. https:\/\/doi.org\/10.1021\/ac051632c.","journal-title":"Anal Chem."},{"issue":"4","key":"437_CR37","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/brain\/awl023","volume":"129","author":"M Bakay","year":"2006","unstructured":"Bakay M, Wang Z, Melcon G, et al. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb\u2013MyoD pathways in muscle regeneration. Brain. 2006;129(4):996\u20131013. https:\/\/doi.org\/10.1093\/brain\/awl023.","journal-title":"Brain"},{"issue":"4","key":"437_CR38","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1096\/fj.06-7285com","volume":"21","author":"M Pescatori","year":"2007","unstructured":"Pescatori M, Broccolini A, Minetti C, et al. Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. FASEB J. 2007;21(4):1210\u201326. https:\/\/doi.org\/10.1096\/fj.06-7285com.","journal-title":"FASEB J"},{"issue":"1","key":"437_CR39","doi-asserted-by":"publisher","first-page":"28745","DOI":"10.1038\/s41598-024-79024-8","volume":"14","author":"AB Willis","year":"2024","unstructured":"Willis AB, Zelikovich AS, Sufit R, et al. Serum protein and imaging biomarkers after intermittent steroid treatment in muscular dystrophy. Sci Rep. 2024;14(1):28745. https:\/\/doi.org\/10.1038\/s41598-024-79024-8.","journal-title":"Sci Rep"},{"key":"437_CR40","doi-asserted-by":"publisher","unstructured":"Dergai O, Wuu J, Koziczak-Holbro M, et al. Skeletal muscle biomarkers of amyotrophic lateral sclerosis: a large-scale, multi-cohort proteomic study. Ann Neurol. n\/a(n\/a). https:\/\/doi.org\/10.1002\/ana.78046.","DOI":"10.1002\/ana.78046"},{"issue":"9","key":"437_CR41","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41419-023-06103-5","volume":"14","author":"X Su\u00e1rez-Calvet","year":"2023","unstructured":"Su\u00e1rez-Calvet X, Fern\u00e1ndez-Sim\u00f3n E, Natera D, et al. Decoding the transcriptome of Duchenne muscular dystrophy to the single nuclei level reveals clinical-genetic correlations. Cell Death Dis. 2023;14(9):596. https:\/\/doi.org\/10.1038\/s41419-023-06103-5.","journal-title":"Cell Death Dis"},{"key":"437_CR42","doi-asserted-by":"publisher","unstructured":"Yoshida K, Reeves C, Vink J, et al. Cervical Collagen Network Remodeling in Normal Pregnancy and Disrupted Parturition in Antxr2 Deficient Mice. J Biomech Eng. 2014;136(021017). https:\/\/doi.org\/10.1115\/1.4026423.","DOI":"10.1115\/1.4026423"},{"issue":"4","key":"437_CR43","doi-asserted-by":"publisher","first-page":"e34862","DOI":"10.1371\/journal.pone.0034862","volume":"7","author":"CV Reeves","year":"2012","unstructured":"Reeves CV, Wang X, Charles-Horvath PC, et al. Anthrax Toxin Receptor 2 Functions in ECM Homeostasis of the Murine Reproductive Tract and Promotes MMP Activity. PLoS One. 2012;7(4):e34862. https:\/\/doi.org\/10.1371\/journal.pone.0034862.","journal-title":"PLoS One"},{"key":"437_CR44","doi-asserted-by":"publisher","unstructured":"Metti S, Bracq LJ, Signor M, et al. Antxr2-mediated fine-tuning of Collagen VI ensures skeletal muscle function. bioRxiv. Preprint posted online September 19, 2025:2025.09.11.675515. https:\/\/doi.org\/10.1101\/2025.09.11.675515.","DOI":"10.1101\/2025.09.11.675515"},{"issue":"4","key":"437_CR45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11626-021-00555-9","volume":"57","author":"A do Carmo Costa","year":"2021","unstructured":"do Carmo Costa A, Copola AGL, Carvalho e Souza C, Nogueira JM, Silva GAB, Jorge EC. RGMa can induce skeletal muscle cell hyperplasia via association with neogenin signalling pathway. In Vitro Cell Dev Biol Anim. 2021;57(4):415\u201327. https:\/\/doi.org\/10.1007\/s11626-021-00555-9.","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"3","key":"437_CR46","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/jcsm.12405","volume":"10","author":"MC Hughes","year":"2019","unstructured":"Hughes MC, Ramos SV, Turnbull PC, et al. Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H2 O2 emission during impaired oxidative phosphorylation. J Cachexia Sarcopenia Muscle. 2019;10(3):643\u201361. https:\/\/doi.org\/10.1002\/jcsm.12405.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"437_CR47","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1253\/circj.71.693","volume":"71","author":"SB Chai","year":"2007","unstructured":"Chai SB, Hui YM, Li XM, Tang CS. Plasma Level of Mitochondrial Coupling Factor 6 Increases in Patients With Coronary Heart Disease. Circ J. 2007;71(5):693\u20137. https:\/\/doi.org\/10.1253\/circj.71.693.","journal-title":"Circ J"},{"issue":"12","key":"437_CR48","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1172\/JCI42390","volume":"120","author":"R Han","year":"2010","unstructured":"Han R, Frett EM, Levy JR, et al. Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice. J Clin Invest. 2010;120(12):4366\u201374. https:\/\/doi.org\/10.1172\/JCI42390.","journal-title":"J Clin Invest"}],"container-title":["Skeletal Muscle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13395-026-00437-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-026-00437-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-026-00437-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:03:00Z","timestamp":1791475380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13395-026-00437-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["437"],"URL":"https:\/\/doi.org\/10.1186\/s13395-026-00437-2","relation":{},"ISSN":["2044-5040"],"issn-type":[{"value":"2044-5040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The FOR-DMD study was registered at\u00a0ClinicalTrials.gov\u00a0(no.\u00a0NCT01603407). Serum samples and clinical data were collected following approval from the competent ethics committee at each institution in accordance with the International Conference on Harmonisation guidelines for Good Clinical Practice and the World Medical Association Declaration of Helsinki. Central Institutional Review Board (IRB) approval for the original FOR-DMD study was obtained from the University of Rochester Ethics Committee\/IRB and Newcastle Clinical Trial Unit (NCTU) before distribution of study documents to each investigative site and enrollment of participants. Informed written consent for participation in biomarker research was obtained from the parents or legal guardians of participants at the time of enrollment in the clinical study. For the data collected retrospectively at Leiden University Medical Center (LUMC), written informed consent was obtained from all participants or their legal guardians in accordance with protocol B22.013, approved by the regulatory board at LUMC, called \"Medische Ethische Toetsings Commissie\" (METC, medical ethics review committee).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"37"}}